Picture of Biomerica logo

BMRA — Biomerica News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Biomerica Inc expected to post a loss of 12 cents a share - Earnings Preview

* Biomerica Inc  BMRA.OQ   BMRA.O  is expected to show a rise in
quarterly revenue when it reports results on October 13
(estimated). 
* The Irvine, California-based company is expected to report  a
66.1% increase in revenue to $1.9 million from $1.14 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
​* Refinitiv's mean analyst estimate for Biomerica Inc is for a
loss of 12 cents per share. For the same quarter last year, the
company reported a loss of 14 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts had fallen by
about 10.0% in the last three months. ​
* Wall Street's median 12-month price target for Biomerica Inc
is $12​, about 44.1% above​ its last closing price of $6.71. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 May. 31 2021              -0.11      -0.12     Missed  -10.4
 Feb. 28 2021  -0.03       -0.08      -0.15     Missed  -87.5
 Nov. 30 2020  -0.10       -0.10      -0.13     Missed  -33.3​
 Aug. 31 2020  -0.08       -0.08      -0.14     Missed  -75
 May.          -0.07​      -0.07      -0.04     Beat    40​
 31​ 2020​                                              
 Feb. 29 2020  -0.07       -0.06      -0.09     Missed  -38.5​
 Nov. 30 2019              -0.08      -0.05     Beat    37.5
 Aug. 31 2019  -0.06       -0.06      -0.05     Beat    16.7
 This summary was machine generated October 11 at 20:04 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Biomerica

See all news